{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T14:50:12Z","timestamp":1795099812574,"version":"4.10.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To better combat bacterial antibiotic resistance, a growing global health threat, it is imperative to understand its drivers and underlying biological mechanisms.\u00a0One potential driver of antibiotic resistance\u00a0is exposure to sub-inhibitory concentrations of antibiotics. This occurs in both the environment and clinic, from agricultural contamination to incorrect dosing and usage of poor-quality medicines. To better understand this driver, we tested the effect of a broad range of ciprofloxacin concentrations on antibiotic resistance development in <jats:italic>Escherichia coli<\/jats:italic>. We observed the emergence of stable, low-level multi-drug resistance that was both time and concentration dependent. Furthermore, we identified a spectrum of single mutations in strains with resistant phenotypes, both previously described and novel. Low-level class-wide resistance, which often goes undetected in the clinic, may allow for bacterial survival and establishment of a reservoir for outbreaks of high-level antibiotic resistant infections.<\/jats:p>","DOI":"10.1038\/s41598-020-65602-z","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T10:02:27Z","timestamp":1590746547000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Development and selection of low-level multi-drug resistance over an extended range of sub-inhibitory ciprofloxacin concentrations in Escherichia coli"],"prefix":"10.1038","volume":"10","author":[{"given":"Carly","family":"Ching","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad H.","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"65602_CR1","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.mib.2012.07.005","volume":"15","author":"D Hughes","year":"2012","unstructured":"Hughes, D. & Andersson, D. I. Selection of resistance at lethal and non-lethal antibiotic concentrations. Curr. Opin. Microbiol. 15, 555\u2013560 (2012).","journal-title":"Curr. Opin. Microbiol."},{"key":"65602_CR2","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.2134\/jeq2012.0014","volume":"41","author":"R Wei","year":"2012","unstructured":"Wei, R., Ge, F., Chen, M. & Wang, R. Occurrence of ciprofloxacin, enrofloxacin, and florfenicol in animal wastewater and water resources. J. Environ. Qual. 41, 1481\u20131486 (2012).","journal-title":"J. Environ. Qual."},{"key":"65602_CR3","doi-asserted-by":"crossref","unstructured":"Sukul, P. & Spiteller, M. Fluoroquinoloe Antibiotics in the Environment. in Reviews of Environmental Contamination and Toxicology 131\u2013162 (2007).","DOI":"10.1007\/978-0-387-69163-3_5"},{"key":"65602_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S1473-3099(18)30279-2","volume":"18","author":"H Fisher","year":"2018","unstructured":"Fisher, H. et al. Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial. Lancet Infect. Dis. 18, 957\u2013968 (2018).","journal-title":"Lancet Infect. Dis."},{"key":"65602_CR5","first-page":"443","volume":"28","author":"T Kelesidis","year":"2015","unstructured":"Kelesidis, T. & Falagas, E. Substandard \/ Counterfeit Antimicrobial Drugs. 28, 443\u2013464 (2015).","journal-title":"Substandard \/ Counterfeit Antimicrobial Drugs."},{"key":"65602_CR6","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrmicro3270","volume":"12","author":"DI Andersson","year":"2014","unstructured":"Andersson, D. I. & Hughes, D. Microbiological effects of sublethal levels of antibiotics. Nat. Rev. Microbiol. 12, 465\u2013478 (2014).","journal-title":"Nat. Rev. Microbiol."},{"key":"65602_CR7","doi-asserted-by":"crossref","unstructured":"Wistrand-Yuen, E. et al. Evolution of high-level resistance during low-level antibiotic exposure. Nat. Commun. 9 (2018).","DOI":"10.1038\/s41467-018-04059-1"},{"key":"65602_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s13213-011-0260-3","volume":"62","author":"H Bai","year":"2012","unstructured":"Bai, H. et al. Analysis of mechanisms of resistance and tolerance of Escherichia coli to enrofloxacin. Ann. Microbiol. 62, 293\u2013298 (2012).","journal-title":"Ann. Microbiol."},{"key":"65602_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1128\/AAC.45.3.938-942.2001","volume":"45","author":"M Boos","year":"2001","unstructured":"Boos, M. et al. In vitro development of resistance to six quinolones in Streptococcus pneumoniae, Streptococcus pyogenes, and Staphylococcus aureus. Antimicrob. Agents Chemother. 45, 938\u2013942 (2001).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65602_CR10","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0924-8579(02)00120-6","volume":"20","author":"FA Browne","year":"2002","unstructured":"Browne, F. A. et al. Single and multi-step resistance selection study in Streptococcus pneumoniae comparing ceftriaxone with levofloxacin, gatifloxacin and moxifloxacin. Int. J. Antimicrob. Agents 20, 93\u201399 (2002).","journal-title":"Int. J. Antimicrob. Agents"},{"key":"65602_CR11","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1128\/AAC.43.5.1177","volume":"43","author":"TA Davies","year":"1999","unstructured":"Davies, T. A., Pankuch, G. A., Dewasse, B. E., Jacobs, M. R. & Appelbaum, P. C. In vitro development of resistance to five quinolones and amoxicillin-clavulanate in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 43, 1177\u20131182 (1999).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"65602_CR12","doi-asserted-by":"publisher","first-page":"e030747","DOI":"10.1136\/bmjopen-2019-030747","volume":"9","author":"Carly Ching","year":"2019","unstructured":"Ching, C., Orubu, E. S. F., Wirtz, V. J. & Zaman, M. H. Bacterial antibiotic resistance development and mutagenesis following exposure to subminimal inhibitory concentrations of fluoroquinolones in vitro: a systematic literature review protocol. BMJ Open 1\u20136. https:\/\/doi.org\/10.1136\/bmjopen-2019-030747 (2019)","journal-title":"BMJ Open"},{"key":"65602_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0732-8893(89)90019-9","volume":"12","author":"KE Aldridge","year":"1989","unstructured":"Aldridge, K. E. et al. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance. Diagn. Microbiol. Infect. Dis. 12, 221\u2013233 (1989).","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"65602_CR14","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/jac\/dkm292","volume":"60","author":"L Avrain","year":"2007","unstructured":"Avrain, L. et al. Selection of quinolone resistance in Streptococcus pneumoniae exposed in vitro to subinhibitory drug concentrations. J Antimicrob Chemother 60, 965\u2013972 (2007).","journal-title":"J Antimicrob Chemother"},{"key":"65602_CR15","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1128\/AAC.25.6.775","volume":"25","author":"AL Barry","year":"1984","unstructured":"Barry, A. L. & Jones, R. N. Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin, and oxolinic acid after in vitro selection of resistant populations. Antimicrob. Agents Chemother. 25, 775\u2013777 (1984).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65602_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1093\/jac\/dkg054","volume":"51","author":"D Jonas","year":"2003","unstructured":"Jonas, D. et al. Development and mechanism of fluoroquinolone resistance in Legionella pneumophila. J. Antimicrob. Chemother. 51, 275\u2013280 (2003).","journal-title":"J. Antimicrob. Chemother."},{"issue":"9","key":"65602_CR17","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1136\/bjo.2004.059519","volume":"89","author":"R E Weir","year":"2005","unstructured":"Weir, R. et al. Variability in the content of Indian generic ciprofloxacin eye drops. 1094\u20131096, https:\/\/doi.org\/10.1136\/bjo.2004.059519 (2005)","journal-title":"British Journal of Ophthalmology"},{"key":"65602_CR18","doi-asserted-by":"crossref","unstructured":"Frimpong, G. et al. Quality Assessment of Some Essential Children\u2019s Medicines Sold in Licensed Outlets in Ashanti Region, Ghana. 2018 (2018).","DOI":"10.1155\/2018\/1494957"},{"key":"65602_CR19","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1093\/jac\/dkz164","volume":"74","author":"P Tabernero","year":"2019","unstructured":"Tabernero, P. et al. A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR. J. Antimicrob. Chemother. 74, 2417\u20132425 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"65602_CR20","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3947\/ic.2014.46.4.226","volume":"46","author":"ES Kim","year":"2014","unstructured":"Kim, E. S. & Hooper, D. C. Clinical importance and epidemiology of quinolone resistance. Infect. Chemother. 46, 226\u2013238 (2014).","journal-title":"Infect. Chemother."},{"key":"65602_CR21","doi-asserted-by":"crossref","unstructured":"McEwen, S. A. & Fedorka-Cray, P. J. Antimicrobial Use and Resistance in Animals. Clin. Infect. Dis. 34, Supplement (2002).","DOI":"10.1086\/340246"},{"key":"65602_CR22","unstructured":"Acar, J. F. & Goldstein, F. W. Trends in Bacterial Resistance to Fluoroquinolones. Clin. Infect. Dis., 24 (1999)."},{"key":"65602_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/976273","volume":"2012","author":"Axel Dalhoff","year":"2012","unstructured":"Dalhoff, A. Global Fluoroquinolone Resistance Epidemiology and Implictions for Clinical Use. Interdiscip. Persepctives Infect. Dsiseases 2012 (2012).","journal-title":"Interdisciplinary Perspectives on Infectious Diseases"},{"key":"65602_CR24","doi-asserted-by":"crossref","unstructured":"Zayed, A. A. F., Essam, T. M., Hashem, A. G. M. & El-Tayeb, O. M. \u2018Supermutators\u2019 found amongst highly levofloxacin-resistant E. coli isolates: A rapid protocol for the detection of mutation sites. Emerg. Microbes Infect. 4 (2015).","DOI":"10.1038\/emi.2015.4"},{"key":"65602_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/(SICI)1098-2280(1996)27:2<110::AID-EM6>3.0.CO;2-K","volume":"27","author":"B Clerch","year":"1996","unstructured":"Clerch, B., Bravo, J. M. & Llagostera, M. Analysis of the ciprofloxacin-induced mutations in Salmonella typhimurium. Environ. Mol. Mutagen. 27, 110\u2013115 (1996).","journal-title":"Environ. Mol. Mutagen."},{"key":"65602_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-09111-6","volume":"7","author":"GL Isom","year":"2017","unstructured":"Isom, G. L. et al. MCE domain proteins: Conserved inner membrane lipid-binding proteins required for outer membrane homeostasis. Sci. Rep. 7, 1\u201312 (2017).","journal-title":"Sci. Rep."},{"key":"65602_CR27","doi-asserted-by":"crossref","unstructured":"Matern, Y., Barion, B. & Behrens-Kneip, S. PpiD is a player in the network of periplasmic chaperones in Escherichia coli. BMC Microbiol. 10 (2010).","DOI":"10.1186\/1471-2180-10-251"},{"key":"65602_CR28","doi-asserted-by":"publisher","first-page":"12300","DOI":"10.1074\/jbc.M113.529164","volume":"289","author":"A Mustaev","year":"2014","unstructured":"Mustaev, A. et al. Fluoroquinolone-gyrase-DNA complexes two modes of drug binding. J. Biol. Chem. 289, 12300\u201312312 (2014).","journal-title":"J. Biol. Chem."},{"key":"65602_CR29","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3201\/eid0702.010239","volume":"7","author":"DC Hooper","year":"2001","unstructured":"Hooper, D. C. Emerging mechanisms of fluoroquinolone resistance. Emerg. Infect. Dis. 7, 337\u2013341 (2001).","journal-title":"Emerg. Infect. Dis."},{"key":"65602_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/jac\/dky417","volume":"74","author":"BCL Van Der Putten","year":"2019","unstructured":"Van Der Putten, B. C. L. et al. Quantifying the contribution of four resistance mechanisms to ciprofloxacin MIC in Escherichia coli: A systematic review. J. Antimicrob. Chemother. 74, 298\u2013310 (2019).","journal-title":"J. Antimicrob. Chemother."},{"key":"65602_CR31","doi-asserted-by":"publisher","first-page":"7293","DOI":"10.1073\/pnas.0401595101","volume":"101","author":"KD Corbett","year":"2004","unstructured":"Corbett, K. D., Shultzaberger, R. K. & Berger, J. M. The C-terminal domain of DNA gyrase A adopts a DNA-bending \u03b2-pinwheel fold. Proc. Natl. Acad. Sci. USA 101, 7293\u20137298 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"65602_CR32","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.1128\/AAC.42.10.2661","volume":"42","author":"LM Weigel","year":"1998","unstructured":"Weigel, L. M., Steward, C. D. & Tenover, F. C. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrob. Agents Chemother. 42, 2661\u20132667 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65602_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1128\/AAC.37.1.126","volume":"37","author":"CJR Willmott","year":"1993","unstructured":"Willmott, C. J. R. & Maxwell, A. A single point mutation in the DNA gyrase A protein greatly reduces binding of fluoroquinolones to the gyrase-DNA complex. Antimicrob. Agents Chemother. 37, 126\u2013127 (1993).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65602_CR34","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","volume":"16","author":"D Du","year":"2018","unstructured":"Du, D. et al. Multidrug efflux pumps: structure, function and regulation. Nat. Rev. Microbiol. 16, 523\u2013539 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"65602_CR35","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1128\/JB.185.19.5657-5664.2003","volume":"185","author":"EW Yu","year":"2003","unstructured":"Yu, E. W., Aires, J. R. & Nikaido, H. AcrB multidrug efflux pump of Escherichia coli: Composite substrate-binding cavity of exceptional flexibility generates its extremely wide substrate specificity. J. Bacteriol. 185, 5657\u20135664 (2003).","journal-title":"J. Bacteriol."},{"key":"65602_CR36","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1128\/JB.178.1.306-308.1996","volume":"178","author":"H Okusu","year":"1996","unstructured":"Okusu, H., Ma, D. & Nikaido, H. AcrAB efflux pump plays a major role in the antibiotic resistance phenotype of Escherichia coli multiple-antibiotic-resistance (Mar) mutants. J. Bacteriol. 178, 306\u2013308 (1996).","journal-title":"J. Bacteriol."},{"key":"65602_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1046\/j.1365-2958.1996.357881.x","volume":"19","author":"D Ma","year":"1996","unstructured":"Ma, D., Alberti, M., Lynch, C., Nikaido, H. & Hearst, J. E. The local repressor AcrR plays a modulating role in the regulation of acrAB genes of Escherichia coli by global stress signals. Mol. Microbiol. 19, 101\u2013112 (1996).","journal-title":"Mol. Microbiol."},{"key":"65602_CR38","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1128\/JB.175.10.2888-2894.1993","volume":"175","author":"L Gambino","year":"1993","unstructured":"Gambino, L., Gracheck, S. J. & Miller, P. F. Overexpression of the marA positive regulator is sufficient to confer multiple antibiotic resistance in Escherichia coli. J. Bacteriol. 175, 2888\u20132894 (1993).","journal-title":"J. Bacteriol."},{"key":"65602_CR39","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1128\/JB.175.5.1484-1492.1993","volume":"175","author":"SP Cohen","year":"1993","unstructured":"Cohen, S. P., Hachler, H. & Levy, S. B. Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. J. Bacteriol. 175, 1484\u20131492 (1993).","journal-title":"J. Bacteriol."},{"key":"65602_CR40","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1128\/AAC.40.5.1266","volume":"40","author":"JD Goldman","year":"1996","unstructured":"Goldman, J. D., White, D. G. & Levy, S. B. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrob. Agents Chemother. 40, 1266\u20131269 (1996).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65602_CR41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.jmb.2007.09.064","volume":"374","author":"M Li","year":"2007","unstructured":"Li, M. et al. Crystal Structure of the Transcriptional Regulator AcrR from Escherichia coli. J. Mol. Biol. 374, 591\u2013603 (2007).","journal-title":"J. Mol. Biol."},{"key":"65602_CR42","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1093\/jac\/dkv475","volume":"71","author":"M Adler","year":"2016","unstructured":"Adler, M., Anjum, M., Andersson, D. I. & Sandegren, L. Combinations of mutations in envZ, ftsI, mrdA, acrB and acrR can cause high-level carbapenem resistance in Escherichia coli. J. Antimicrob. Chemother. 71, 1188\u20131198 (2016).","journal-title":"J. Antimicrob. Chemother."},{"key":"65602_CR43","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/90429","volume":"8","author":"MN Alekshun","year":"2001","unstructured":"Alekshun, M. N., Levy, S. B., Mealy, T. R., Seaton, B. A. & Head, J. F. The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 \u00c5 resolution. Nat. Struct. Biol. 8, 710\u2013714 (2001).","journal-title":"Nat. Struct. Biol."},{"key":"65602_CR44","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1128\/JB.02224-12","volume":"195","author":"V Duval","year":"2013","unstructured":"Duval, V., McMurry, L. M., Foster, K., Head, J. F. & Levy, S. B. Mutational analysis of the multiple-antibiotic resistance regulator marR reveals a ligand binding pocket at the interface between the dimerization and DNA binding domains. J. Bacteriol. 195, 3341\u20133351 (2013).","journal-title":"J. Bacteriol."},{"key":"65602_CR45","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1046\/j.1365-2958.2000.01802.x","volume":"35","author":"MN Alekshun","year":"2000","unstructured":"Alekshun, M. N., Kim, Y. S. & Levy, S. B. Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding. Mol. Microbiol. 35, 1394\u20131404 (2000).","journal-title":"Mol. Microbiol."},{"key":"65602_CR46","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1128\/AAC.47.10.3222-3232.2003","volume":"47","author":"PK Lindgren","year":"2003","unstructured":"Lindgren, P. K., Karlsson, \u00c5. & Hughes, D. Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob. Agents Chemother. 47, 3222\u20133232 (2003).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65602_CR47","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1128\/AAC.44.4.814-820.2000","volume":"44","author":"WV Kern","year":"2000","unstructured":"Kern, W. V., Oethinger, M., Jellen-Ritter, A. S. & Levy, S. B. Non-target gene mutations in the development of fluoroquinolone resistance in Escherichia coli. Antimicrob. Agents Chemother. 44, 814\u2013820 (2000).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65602_CR48","doi-asserted-by":"crossref","unstructured":"L\u00e1z\u00e1r, V. et al. Genome-wide analysis captures the determinants of the antibiotic cross-resistance interaction network. Nat. Commun. 5 (2014).","DOI":"10.1038\/ncomms5352"},{"key":"65602_CR49","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1093\/jac\/dkx270","volume":"72","author":"LP Alzrigat","year":"2017","unstructured":"Alzrigat, L. P., Huseby, D. L., Brandis, G. & Hughes, D. Fitness cost constrains the spectrum of marR mutations in ciprofloxacin-resistant Escherichia coli. J. Antimicrob. Chemother. 72, 3016\u20133024 (2017).","journal-title":"J. Antimicrob. Chemother."},{"key":"65602_CR50","first-page":"751","volume":"413","author":"S Shoji","year":"2013","unstructured":"Shoji, S., Dambacher, C. M., Shajani, Z. & Williamson, J. R. Systemic Deletion of Ribosome Assembly Genes in E. Coli. 413, 751\u2013761 (2013).","journal-title":"Coli."},{"key":"65602_CR51","first-page":"1029","volume":"34","author":"DL Huseby","year":"2017","unstructured":"Huseby, D. L. et al. Mutation Supply and Relative Fitness Shape the Genotypes of Ciprofloxacin-Resistant Escherichia coli. Mol. Biol. Evol. 34, 1029\u20131039 (2017).","journal-title":"Mol. Biol. Evol."},{"key":"65602_CR52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.aay3041","volume":"367","author":"J Liu","year":"2020","unstructured":"Liu, J., Gefen, O., Ronin, I., Bar-Meir, M. & Balaban, N. Q. Effect of tolerance on the evolution of antibiotic resistance under drug combinations. Science 367, 200\u2013204 (2020).","journal-title":"Science"},{"key":"65602_CR53","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1128\/AAC.42.8.2089","volume":"42","author":"M Oethinger","year":"1998","unstructured":"Oethinger, M., Podglajen, I., Kern, W. V. & Levy, S. B. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrob. Agents Chemother. 42, 2089\u20132094 (1998).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65602_CR54","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1054\/drup.2001.0196","volume":"4","author":"F Baquero","year":"2001","unstructured":"Baquero, F. Low-level antibacterial resistance: A gateway to clinical resistance. Drug Resist. Updat. 4, 93\u2013105 (2001).","journal-title":"Drug Resist. Updat."},{"key":"65602_CR55","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1128\/AAC.00665-08","volume":"53","author":"SK Morgan-Linnell","year":"2009","unstructured":"Morgan-Linnell, S. K., Boyd, L. B., Steffen, D. & Zechiedrich, L. Mechanisms accounting for fluoroquinolone resistance in Escherichia coli clinical isolates. Antimicrob. Agents Chemother. 53, 235\u2013241 (2009).","journal-title":"Antimicrob. Agents Chemother."},{"key":"65602_CR56","first-page":"1","volume":"63","author":"P Szili","year":"2019","unstructured":"Szili, P. et al. Rapid Evolution of Reduced Susceptibility against a Balanced Dual-Targeting Antibiotic through Stepping-Stone Mutations. 63, 1\u201315 (2019).","journal-title":"Rapid Evolution of Reduced Susceptibility against a Balanced Dual-Targeting Antibiotic through Stepping-Stone Mutations."},{"key":"65602_CR57","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1099\/jmm.0.45908-0","volume":"54","author":"AM Ahmed","year":"2005","unstructured":"Ahmed, A. M., Miyoshi, S. I., Shinoda, S. & Shimamoto, T. Molecular characterization of a multidrug-resistant strain of enteroinvasive Escherichia coli O164 isolated in Japan. J. Med. Microbiol. 54, 273\u2013278 (2005).","journal-title":"J. Med. Microbiol."},{"key":"65602_CR58","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.2147\/IDR.S203661","volume":"12","author":"GL Paniagua-Contreras","year":"2019","unstructured":"Paniagua-Contreras, G. L. et al. Whole-genome sequence analysis of multidrug-resistant uropathogenic strains of Escherichia coli from Mexico. Infect. Drug Resist. 12, 2363\u20132377 (2019).","journal-title":"Infect. Drug Resist."},{"key":"65602_CR59","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1128\/AAC.49.6.2343-2351.2005","volume":"49","author":"P Komp Lindgren","year":"2005","unstructured":"Komp Lindgren, P., Marcusson, L. L., Sandvang, D. & Hughes, D. Biological Cost of Single and Multiple Norfloxacin Resistance Mutations in. Antimicrob Agents Chemother 49, 2343\u20132351 (2005).","journal-title":"Antimicrob Agents Chemother"},{"key":"65602_CR60","first-page":"1","volume":"5","author":"S Suzuki","year":"2014","unstructured":"Suzuki, S., Horinouchi, T. & Furusawa, C. Prediction of antibiotic resistance by gene expression profiles. Nat. Commun. 5, 1\u201312 (2014).","journal-title":"Nat. Commun."},{"key":"65602_CR61","unstructured":"Chantell, C., Humphries, R. M. & Lewis, J. S. Fluoroquinolone Breakpoints for Enterobacteriaceae and Pseudomonas aeruginosa CLSI rationale document MR02 Oregon Health and Science University. (2019)."},{"key":"65602_CR62","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.1128\/AAC.01565-09","volume":"54","author":"Q Wang","year":"2010","unstructured":"Wang, Q. et al. Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis. Antimicrob. Agents Chemother. 54, 2707\u20132711 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"issue":"suppl_1","key":"65602_CR63","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/jac\/48.suppl_1.5","volume":"48","author":"Jennifer M. Andrews","year":"2001","unstructured":"Andrews, J. M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 5\u201316 (2001).","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"65602_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0167-7012(02)00226-9","volume":"53","author":"JD Brewster","year":"2003","unstructured":"Brewster, J. D. A simple micro-growth assay for enumerating bacteria. J. Microbiol. Methods 53, 77\u201386 (2003).","journal-title":"J. Microbiol. Methods"},{"key":"65602_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AEM.02724-17","volume":"84","author":"H Shakeri","year":"2018","unstructured":"Shakeri, H. et al. Establishing statistical equivalence of data from different sampling approaches for assessment of bacterial phenotypic antimicrobial resistance. Appl. Environ. Microbiol. 84, 1\u201316 (2018).","journal-title":"Appl. Environ. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65602-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65602-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T11:48:32Z","timestamp":1670327312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-65602-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["65602"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-65602-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"2 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8754"}}